Interview: Quintiles India CEO on green shoots, digital patients & white noise
This article was originally published in Scrip
Executive Summary
Naz Haji, Quintiles' new country CEO for India, claims there are green shoots in India's beleaguered clinical research segment. Sponsors, he says, are beginning to reassess decisions to move studies away from the country, although he admits the confidence gap may take a while to bridge.